Insider Transactions in Q1 2026 at Beta Bionics, Inc. (BBNX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 13
2026
|
Danny L. Dearen |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+20.77%
|
-
|
|
Jan 13
2026
|
Adam Lezack |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+24.33%
|
-
|
|
Jan 13
2026
|
Christy Jones |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+20.77%
|
-
|
|
Jan 13
2026
|
Maria Palasis |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+24.33%
|
-
|
|
Jan 13
2026
|
Sean Carney |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+20.77%
|
-
|
|
Jan 13
2026
|
Gerard J Michel |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+19.46%
|
-
|
|
Jan 06
2026
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
2,200
-2.65%
|
$66,000
$30.1 P/Share
|
|
Jan 02
2026
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
7,800
-4.33%
|
$226,200
$29.88 P/Share
|
|
Jan 02
2026
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-31.94%
|
$580,000
$29.53 P/Share
|
|
Jan 02
2026
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+24.21%
|
$100,000
$5.1 P/Share
|